Apteka Exhibition Russian Health Care Week UFI Approved Event
To main
For exhibitors
For visitors

Sanofi's Lemtrada garners EU approval for multiple sclerosis


Sanofi’s Genzyme unit announced Tuesday that the European Commission approved Lemtrada (alemtuzumab) for the treatment of adults with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features. The company noted that the FDA is expected to decide on a filing for the drug in late 2013. Genzyme CEO David Meeker said «this is particularly exciting as the EU approval is the first for Lemtrada globally.»

Source: firstwordpharma.com

Back to the list

Invite partners to the exhibition
Facebook Youtube RSS Feed

Contacts Flashback Site map
119002 Moscow, Arbat str., 35, of. 423
Тel: +7 (495) 925-65-61/62
Fax: +7 (499) 248-07-34